Association of polymorphisms in neuroprotection and oxidative stress genes and neurodevelopmental outcomes after preterm birth

Obstetrics and Gynecology

Volumn 120, Issue 3, 2012, Pages 542-550

  Costantine, Maged M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Clark, Erin A S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Lai, Yinglei ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Rouse, Dwight J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Spong, Catherine Y ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Mercer, Brian M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Sorokin, Yoram ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Thorp, John M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Ramin, Susan M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Malone, Fergal D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Carpenter, Marshall ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Miodovnik, Menachem ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   O'Sullivan, Mary J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Peaceman, Alan M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Caritis, Steve N ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ Howard Hughes Medical Institute   (United States)

^j BROWN UNIVERSITY   (United States)

^k UNIVERSITY OF CINCINNATI   (United States)

^l UNIVERSITY OF MIAMI   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ UNIVERSITY OF PITTSBURGH   (United States)

^o GEORGE WASHINGTON UNIVERSITY   (United States)

^p EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AQUAPORIN 4; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE PEROXIDASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; KALIRIN; MAGNESIUM SULFATE; MANGANESE SUPEROXIDE DISMUTASE; N METHYL ASPARTATE RECEPTOR SUBUNIT 2B; N METHYL ASPARTATE RECEPTOR SUBUNIT 3A; N METHYL ASPARTATE RECEPTOR SUBUNIT 3B; N METHYL ASPARTATE RECEPTOR SUBUNIT A; NEU DIFFERENTIATION FACTOR; PREALBUMIN; PROTEIN; REELIN; TOLL LIKE RECEPTOR 4; TRANSIENT RECEPTOR POTENTIAL MELASTATIN 7; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; VASOACTIVE INTESTINAL POLYPEPTIPE;

ARTICLE; CEREBRAL PALSY; EDUCATION; FEMALE; GENETIC ASSOCIATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL ATTITUDE; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPROTECTION; NEWBORN; NEWBORN DEATH; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD BLOOD;

CASE-CONTROL STUDIES; CEREBRAL PALSY; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; GENETIC MARKERS; HOMEOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTELLECTUAL DISABILITY; LOGISTIC MODELS; MALE; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, N-METHYL-D-ASPARTATE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84865625813     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318265f232     Document Type: Article

References (34)

1. American College of Obstetricians and Gynecologists, American Academy of Pediatrics. Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology. Washington, DC: ACOG; 2003.
2. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 2006;33:251-67. (Pubitemid 43831170)
3. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371: 261-9.
4. Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden: VIII. Prevalence and origin in the birth year period 1991-94. Acta Paediatr 2001; 90:271-7. (Pubitemid 32299545)
5. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008;359:895-905.
6. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. The Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004661. DOI: 10.1002/14651858/CD004661.pub3.
7. Costantine MM, Weiner SJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroproetction and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009;114: 354-64.
8. O'Callaghan ME, MacLennan AH, Haan EA, Dekker G, South Australian Cerebral Palsy Research Group. The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum Genet. 2009;126:149-72.
9. Clark EA, Mele L, Wapner RJ, Spong CY, Sorokin Y, Peac-man A, et al. Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Am J Obstet Gynecol 2010;203:83.e1-10
10. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Controlled Clin Trials 1988;9:345-64. (Pubitemid 19012638)
11. Kleffner I, Bungeroth M, Schiffbauer H Schäbitz WR, Ringel-stein EB, Kuhlenbäumer G. The role of aquaporin-4 polymorphism in the development of brain edema after middle cerebral artery occlusion. Stroke 2008;39:1333-5. (Pubitemid 351440711)
12. Sorani MD, Manley GT, Giacomini KM. Genetic variation in human aquaporins and effects on phenotypes of water homeo-stasis. Hum Mutat 2008;29:1108-17.
13. Dai Q, Shrubsole MJ, Ness RM, Schlundt D, Cai Q, Smalley WE, et al. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 2007;86:743-51. (Pubitemid 47435843)
14. Delgado M, Robledo G, Rueda B, Varela N, O'Valle F, Hernandez-Cortes P, Caro M, Orozco G, et al. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis altered expression and signal in immune cells. Arthritis Rheumatism 2008;58:1010-9. (Pubitemid 351564002)
15. Sun W, Hong J, Zang YC, Liu X, Zhang JZ. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis. Int Immunol 2006;18:1691-700. (Pubitemid 44884031)
16. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropscychopharmacology 2010;35:1279-89.
17. Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, et al. A common polymorphism in the brain-derived neu-rotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008;586:5717-25.
18. Serajee FJ, Zhong H, Mahbubul Huq AH. Association of Reelin gene polymorphisms with autism. Genomics 2006;87:75-83. (Pubitemid 43005104)
19. Krug T, Manso H, Gouveia L, Sobral J, Xavier JM, Albergaria I, et al. Kalirin: a novel genetic risk factor for ischemic stroke. Hum Genet 2010;127:513-23.
20. Hoffmann I, Bueter W, Zscheppang K, Brinkhaus MJ, Liese A, Riemke S, et al. Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. Brain Behav Immun 2010;24: 784-91.
21. Li D, He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis. Genet Med 2007;9(1):4-8. (Pubitemid 46105843)
22. Liu HP, Lin WY, Liu SH, Wang WF, Tsai CH, Wu BT, et al. Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease. Dement Geriatr Cogn Disord 2009;28:521-7.
23. Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008;122: 1079-85.
24. Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, et al. Oxidative response gene polymorphisms and risk of adult brain tumors Neuro Oncol 2008;10:709-15.
25. Gaens KHJ, Van Der Kallen CJH, Van Greenvenbroek MMJ, et al. Receptor for advanced glycation end product polymorphisms and type 2 diabetes. The CODAM study. Ann NY Acad Sci 2008;1126:162-5. (Pubitemid 351589275)
26. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91. (Pubitemid 30394990)
27. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
28. Dejda A, Sokolowska P, Nowak JZ. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Rep 2005;57:307-20. (Pubitemid 41030690)
29. Mayer ML. Glutamate receptors at atomic resolution. Nature 2006;440:456-62.
30. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438:1162-6. (Pubitemid 41831686)
31. Alvarez-Diaz A, Hilario E, Goni de Cerio FG, Valls-i-Soler A, Alvarez-Diaz FJ. Hypoxic-ischemic injury in the immature brain-key vascular and cellular players. Neonatology 2007;92: 227-35. (Pubitemid 350125279)
32. Costantine MM, Drever N. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Obstet Gynecol Clin North Am 2011;38:351-66, xi.
33. Buhimschi CS, Baumbusch MA, Dulay AT, Oliver EA, Lee S, Zhao G, et al. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 2009;175:958-75.
34. Costantine MM, Weiner SJ, Rouse DJ, Hirtz DG, Varner MW, Spong CY, et al. Umbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant death. Int J Dev Neurosci. 2011;29:917-22.